校园伴侣校园伴侣,在线视频在线视频bioseutica®

The #1st choice for food, pharma, and feed ingredients

Bioseutica is a world-leading ingredients company whose natural proteins and enzymes are innovative and selected as the first choice for food, pharma, and feed ingredients. Bioseutica aims to become a world market leader catalyzing responsible development of natural high-quality proteins and enzymes. Bioseutica is committed to scientific research leading to innovative products and proprietary technologies. Bioseutica focuses on the global supply of the highest quality bioactive proteins, including egg derived proteins, lysozyme, avidin and ovotransferrin, pancreatic enzymes and specialty products, food ingredients, and feed additives, designed for antibiotic-free livestock, such as aqua, poultry, and swine, and pets. Bioseutica’s manufacturing processes are built on high-end, cutting-edge proprietary technology and allow us to produce ingredients of the highest purities in our manufacturing facilities in Canada and Europe.

Bioseutica 2020 read more Watch the video

Neova Technologies Inc. and Fordras are part of Bioseutica Group. Neova Technologies Inc. draws on almost thirty years of expertise in bioseparation and protein fractionation, building its international reputation on quality and service. Fordras has been serving the pharmaceutical and food industries since 1983. 

Neova Technologies Fordras

 

In 2020 Bioseutica® launched healiva® a new innovative Swiss startup venture located in Lugano. healiva® develops products for regenerative medicine. healiva® uses a multi-pronged approach combining digital health, enzyme technology, and cell therapy to address patient needs for repairing, rescuing, or replacing damaged cells or tissues in their body.

Membership

Bioseutica is a member of DCAT, The Drug, Chemical & Associated Technologies Association (DCAT) powers relationships and industry knowledge for companies engaged in the business of pharmaceutical development and manufacturing. DCAT is a 501(c)6, not-for-profit, member-supported, global business development association whose unique membership model integrates both innovator and generic drug manufacturers and suppliers of ingredients, development and manufacturing services, and related technologies. Founded in 1890, DCAT has been providing a life-long collegial community for industry representatives for over 125 years.  The Drug, Chemical & Associated Technologies Association (DCAT) is a not-for-profit, global business development association whose unique membership model integrates both innovator and generic drug manufacturers and suppliers of ingredients, development, and manufacturing services, and related technologies. We are committed to providing programs, events, and services that help our members meet their business objectives, expand their network of customers and suppliers, and gain insight into industry trends, markets, and those issues impacting pharmaceutical development and manufacturing.

About us

read more

Compliance

Each of Bioseutica's affiliates holds a number of certificates attesting the Company’s commitment to the highest possible quality standards.

  • HACCP certification for our plants in North America
  • Lysozyme Kosher certification
  • Lysozyme Halal certification
  • GMP certificates for Lysozyme plants in EU 
  • Lysozyme is affirmed as GRAS by the US Fed. Register of rules and regulations since 1998
  • GDP by Swissmedic
  • FSSC 22000
KOSHER
HALAL
GMP
HACCP
FSSC

Latest news

Ovotransferrin as a novel drug-targeting molecule for cancer chemotherapy
Ovotransferrin as a novel drug-targeting molecule for cancer chemotherapy

In spite of the numerous discoveries of new anticancer drugs that work on different intracellular targets, many of these drugs have a considerable drawback as they are nonselective thus causing adverse side effects on normal cells. This study is aimed to explore the potential of ovotransferrin (OTf ) as a carrier molecule to allow specific targeting of anticancer drugs to cancer cells via the transferrin receptor (TfR). Receptor binding assay provided evidence that OTf bind to the transferrin-receptor (TfR) of human colon cancer cells.

SARS-COV-2
Lactoferrin, ovotransferrin and lysozyme as antiviral and immune-modulating agents in COVID-19

Coronavirus disease 2019 (COVID-19), caused by SARS coronavirus 2 (SARS-CoV-2), is spreading rapidly with no established effective treatments. While most cases are mild, others experience uncontrolled inflammatory responses with oxidative stress, dysregulation of iron and coagulation as features. Lactoferrin, ovotransferrin and lysozyme are abundant, safe antimicrobials that have wide antiviral as well as immunomodulatory properties. In particular, lactoferrin restores iron homeostasis and inhibits replication of SARS-CoV, which is closely related to SARS-CoV-2.